Literature DB >> 19571584

Long-term trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents.

Agnes van den Hoogen1, Leo J Gerards, Malgorzata A Verboon-Maciolek, André Fleer, Tannette G Krediet.   

Abstract

BACKGROUND: In an era with increased maternal antibiotic use, patterns in early- and late-onset sepsis and antibiotic susceptibility may have changed.
OBJECTIVES: To identify longitudinal trends in causative microorganisms for neonatal sepsis and analyze antibiotic susceptibility of all blood isolates of infants with sepsis.
METHODS: Early- and late-onset sepsis cases from 29 years (1978-2006) were studied retrospectively, in five clusters of 5 years (period I-V) and one cluster of 4 years (period VI), including antibiotic susceptibility profiles of blood isolates during the years 1999-2006.
RESULTS: The incidence of early-onset sepsis decreased (p < 0.01) from 4% during period I (1978-1982) to 1.2% during period VI (2003-2006). 78% of the infants with group B streptococcal (GBS) sepsis were premature during period I, compared to 47% during period VI (p < 0.05). The incidence of early-onset Gram-negative infections remained low during all periods. The incidence of late-onset sepsis, predominantly caused by coagulase-negative staphylococci (CONS) and Staphylococcus aureus, increased since period III from 7.1 to 13.9% in period VI (p < 0.01). Infections due to fungi or yeasts were rare (incidence <0.3%). The majority of CONS blood isolates were oxacillin-resistant, but vancomycin-susceptible. 95% of CONS blood isolates were susceptible for first-generation cephalosporins. Amoxicillin/clavulanic acid-resistant Escherichia coli were infrequent causes of infection.
CONCLUSIONS: The incidence of early-onset sepsis mainly caused by GBS decreased. In contrast, the incidence of late-onset sepsis, predominantly caused by CONS, increased significantly. The incidence of fungal and yeast infections remained low. The majority of CONS blood isolates were susceptible for first-generation cephalosporins. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19571584     DOI: 10.1159/000226604

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  32 in total

1.  Cold spots in neonatal incubators are hot spots for microbial contamination.

Authors:  Marcus C de Goffau; Klasien A Bergman; Hendrik J de Vries; Nico E L Meessen; John E Degener; Jan Maarten van Dijl; Hermie J M Harmsen
Journal:  Appl Environ Microbiol       Date:  2011-10-14       Impact factor: 4.792

2.  Use of the complete blood cell count in late-onset neonatal sepsis.

Authors:  Christoph P Hornik; Daniel K Benjamin; Kristian C Becker; Daniel K Benjamin; Jennifer Li; Reese H Clark; Michael Cohen-Wolkowiez; P Brian Smith
Journal:  Pediatr Infect Dis J       Date:  2012-08       Impact factor: 2.129

Review 3.  Role of innate immunity in neonatal infection.

Authors:  Alex G Cuenca; James L Wynn; Lyle L Moldawer; Ofer Levy
Journal:  Am J Perinatol       Date:  2013-01-07       Impact factor: 1.862

4.  Pharmacokinetics of linezolid treatment using intravenous and oral administrations in extremely premature infants.

Authors:  Mélanie Sicard; Elise Launay; Jocelyne Caillon; Cédric Jacqueline; Arnaud Legrand; Guillaume Deslandes; Dominique Navas; Jean-Christophe Rozé; Christèle Gras-Le Guen
Journal:  Eur J Clin Pharmacol       Date:  2015-03-06       Impact factor: 2.953

5.  Umbilical cord blood procalcitonin level in early neonatal infections: a 4-year university hospital cohort study.

Authors:  N Joram; J-B Muller; S Denizot; J-L Orsonneau; J Caillon; J-C Rozé; C Gras-Le Guen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-02-12       Impact factor: 3.267

6.  Neonatal sepsis in a tertiary care hospital in South India: bacteriological profile and antibiotic sensitivity pattern.

Authors:  Bambala Puthattayil Zakariya; Vishnu Bhat; Belgode Narasimha Harish; Thirunavukkarasu Arun Babu; Noyal Mariya Joseph
Journal:  Indian J Pediatr       Date:  2010-12-17       Impact factor: 1.967

7.  Healthcare associated infections caused by coagulase-negative Staphylococci in a neonatal intensive care unit.

Authors:  André Ricardo Araujo da Silva; Maria Luiza Costa de Lima Simões; Lúcia dos Santos Werneck; Cristiane Henriques Teixeira
Journal:  Rev Bras Ter Intensiva       Date:  2013 Jul-Sep

8.  Duration of vancomycin treatment for coagulase-negative Staphylococcus sepsis in very low birth weight infants.

Authors:  Nehama Linder; Daniel Lubin; Adriana Hernandez; Limor Amit; Shai Ashkenazi
Journal:  Br J Clin Pharmacol       Date:  2013-07       Impact factor: 4.335

9.  Characteristics of late-onset sepsis in the NICU: does occupancy impact risk of infection?

Authors:  N D Goldstein; S C Eppes; B C Ingraham; D A Paul
Journal:  J Perinatol       Date:  2016-05-05       Impact factor: 2.521

10.  Population pharmacokinetics of teicoplanin in children.

Authors:  V Ramos-Martín; S Paulus; S Siner; E Scott; K Padmore; P Newland; R J Drew; T W Felton; F Docobo-Pérez; B Pizer; F Pea; M Peak; M A Turner; M W Beresford; W W Hope
Journal:  Antimicrob Agents Chemother       Date:  2014-09-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.